广发基金全面布局ETF核心赛道，邀您共享投资盛宴！

Core Viewpoint - Guangfa Fund has developed a comprehensive index product line since 2008, focusing on ETF products since 2011, covering multiple markets including A-shares, Hong Kong stocks, and US stocks [1] Group 1: ETF Competition - Guangfa Fund collaborates with CITIC Securities to participate in the 7th ETF live competition, which started registration on December 1, 2025, and will run until January 31, 2026, with the competition commencing on December 8, 2025 [1] - The competition provides a platform for investors to showcase their practical skills, exchange investment strategies, and compete for substantial rewards [1] Group 2: Featured ETF Products - Guangfa Fund selected four key products to support participants in the competition: 1. Hong Kong Stock Connect Technology ETF (159262) closely tracks the Hang Seng Stock Connect Technology Index, focusing on the TMT sector, with major weights in Tencent Holdings, Alibaba-W, and Xiaomi Group-W, accounting for nearly 45% of the index [4] 2. Hong Kong Innovative Drug ETF (513120) tracks the CSI Hong Kong Innovative Drug Index, with a 90% weight in biopharmaceuticals and chemical pharmaceuticals, making it one of the purest innovative drug indices available [4] 3. Growth Enterprise Board ETF Guangfa (159952) tracks the Growth Enterprise Board Index, consisting of 100 stocks with high market capitalization and liquidity, focusing on strategic emerging industries [4] 4. Battery ETF (159755) leads in scale among similar products, tracking the National Index for New Energy Vehicle Batteries, focusing on the battery manufacturing and materials sector, with a solid-state content of nearly 60% [5] Group 3: Future Plans - Guangfa Fund aims to continue deepening its focus on index and ETF sectors, collaborating with partners like CITIC Securities to enhance the index investment ecosystem and help investors share in the long-term growth of the capital market [5]